| UniProt ID | AACT_HUMAN | |
|---|---|---|
| UniProt AC | P01011 | |
| Protein Name | Alpha-1-antichymotrypsin | |
| Gene Name | SERPINA3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 423 | |
| Subcellular Localization | Secreted. | |
| Protein Description | Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2.. | |
| Protein Sequence | MERMLPLLALGLLAAGFCPAVLCHPNSPLDEENLTQENQDRGTHVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 27 | Phosphorylation | AVLCHPNSPLDEENL HHHCCCCCCCCHHHC | 31.15 | 24505115 | |
| 33 | N-linked_Glycosylation | NSPLDEENLTQENQD CCCCCHHHCCCCCCC | 46.47 | 16335952 | |
| 33 | N-linked_Glycosylation | NSPLDEENLTQENQD CCCCCHHHCCCCCCC | 46.47 | 17623646 | |
| 35 | Phosphorylation | PLDEENLTQENQDRG CCCHHHCCCCCCCCC | 45.48 | 26657352 | |
| 93 | N-linked_Glycosylation | FLSLGAHNTTLTEIL HHHHCCCCCCHHHHH | 33.94 | 17623646 | |
| 93 | N-linked_Glycosylation | FLSLGAHNTTLTEIL HHHHCCCCCCHHHHH | 33.94 | 17623646 | |
| 106 | N-linked_Glycosylation | ILKGLKFNLTETSEA HHHHCCCCCCCCCHH | 44.45 | 12754519 | |
| 106 | N-linked_Glycosylation | ILKGLKFNLTETSEA HHHHCCCCCCCCCHH | 44.45 | 18638581 | |
| 127 | N-linked_Glycosylation | QHLLRTLNQSSDELQ HHHHHHHCCCCCHHC | 38.79 | 18638581 | |
| 127 | N-linked_Glycosylation | QHLLRTLNQSSDELQ HHHHHHHCCCCCHHC | 38.79 | 16335952 | |
| 158 | Acetylation | DRFTEDAKRLYGSEA HHHHHHHHHHHCCHH | 56.08 | 12438997 | |
| 177 | Acetylation | FQDSAAAKKLINDYV CCCHHHHHHHHHHHH | 43.30 | 12439007 | |
| 186 | N-linked_Glycosylation | LINDYVKNGTRGKIT HHHHHHHHCCCCCHH | 47.20 | 17623646 | |
| 186 | N-linked_Glycosylation | LINDYVKNGTRGKIT HHHHHHHHCCCCCHH | 47.20 | 16335952 | |
| 191 | Acetylation | VKNGTRGKITDLIKD HHHCCCCCHHHHHHH | 38.86 | 19814787 | |
| 201 | Phosphorylation | DLIKDLDSQTMMVLV HHHHHCCHHHHHHHH | 34.54 | 25003641 | |
| 203 | Phosphorylation | IKDLDSQTMMVLVNY HHHCCHHHHHHHHHH | 15.93 | 25003641 | |
| 210 | Phosphorylation | TMMVLVNYIFFKAKW HHHHHHHHHHHHHCC | 7.51 | 28851738 | |
| 226 | Phosphorylation | MPFDPQDTHQSRFYL CCCCCCCCCCHHEEC | 19.30 | 29083192 | |
| 229 | Phosphorylation | DPQDTHQSRFYLSKK CCCCCCCHHEECCCC | 19.42 | 29083192 | |
| 235 | Acetylation | QSRFYLSKKKWVMVP CHHEECCCCCEEEEE | 56.64 | 81933 | |
| 236 | Acetylation | SRFYLSKKKWVMVPM HHEECCCCCEEEEEC | 48.79 | 81935 | |
| 237 | Acetylation | RFYLSKKKWVMVPMM HEECCCCCEEEEECC | 49.08 | 81937 | |
| 245 | Phosphorylation | WVMVPMMSLHHLTIP EEEEECCCCCCCCCC | 20.49 | 24505115 | |
| 261 | S-nitrosylation | FRDEELSCTVVELKY CCCCCCCEEEEEEEE | 5.38 | 25040305 | |
| 271 | N-linked_Glycosylation | VELKYTGNASALFIL EEEEECCCCEEEEEE | 23.95 | 16335952 | |
| 271 | N-linked_Glycosylation | VELKYTGNASALFIL EEEEECCCCEEEEEE | 23.95 | 18638581 | |
| 273 | Phosphorylation | LKYTGNASALFILPD EEECCCCEEEEEECC | 29.51 | - | |
| 295 | Phosphorylation | EAMLLPETLKRWRDS HHHHCHHHHHHHHHH | 35.32 | 20363803 | |
| 302 | Phosphorylation | TLKRWRDSLEFREIG HHHHHHHHHCHHHCC | 22.64 | 23911959 | |
| 312 | Phosphorylation | FREIGELYLPKFSIS HHHCCCEECCCCEEC | 19.36 | 25690035 | |
| 338 | Phosphorylation | LGIEEAFTSKADLSG HCCHHHHCCCCHHCC | 36.04 | - | |
| 347 | Phosphorylation | KADLSGITGARNLAV CCHHCCCCCCHHHHH | 28.45 | 24505115 | |
| 347 | O-linked_Glycosylation | KADLSGITGARNLAV CCHHCCCCCCHHHHH | 28.45 | 46286157 | |
| 355 | Phosphorylation | GARNLAVSQVVHKAV CCHHHHHHHHHHHHH | 16.20 | 24505115 | |
| 370 | Phosphorylation | LDVFEEGTEASAATA HHHHHHCCHHHHHHH | 31.49 | 24505115 | |
| 373 | Phosphorylation | FEEGTEASAATAVKI HHHCCHHHHHHHHHH | 16.53 | 24505115 | |
| 373 | O-linked_Glycosylation | FEEGTEASAATAVKI HHHCCHHHHHHHHHH | 16.53 | OGP | |
| 381 | O-linked_Glycosylation | AATAVKITLLSALVE HHHHHHHHHHHHHHH | 18.87 | OGP | |
| 381 | Phosphorylation | AATAVKITLLSALVE HHHHHHHHHHHHHHH | 18.87 | 24505115 | |
| 384 | Phosphorylation | AVKITLLSALVETRT HHHHHHHHHHHHCCH | 23.75 | 24505115 | |
| 389 | Phosphorylation | LLSALVETRTIVRFN HHHHHHHCCHHHCCC | 26.15 | 24505115 | |
| 389 | O-linked_Glycosylation | LLSALVETRTIVRFN HHHHHHHCCHHHCCC | 26.15 | OGP | |
| 416 | Acetylation | QNIFFMSKVTNPKQA CCEEEEECCCCCCCC | 41.09 | 7782318 | |
| 421 | Acetylation | MSKVTNPKQA----- EECCCCCCCC----- | 62.01 | 7782318 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AACT_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AACT_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AACT_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RPA12_HUMAN | ZNRD1 | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93; ASN-106; ASN-127 ANDASN-271, AND MASS SPECTROMETRY. | |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-93; ASN-106;ASN-127; ASN-186 AND ASN-271, AND MASS SPECTROMETRY. | |
| "Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93, AND MASS SPECTROMETRY. | |
| "Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-93 AND ASN-106. | |